Limei Zhao

Xinjian South Road No. 56, Yingze District
Taiyuan, 030001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Corrigendum to "Irisin improves acute kidney injury induced by ischemia-reperfusion through targeting energy metabolism reprogramming" [Int. J. Biol. Macromol. 323(Pt 2) (2025) 147073].

Corrigendum to "Irisin improves acute kidney injury induced by ischemia-reperfusion through targeting energy metabolism reprogramming" [Int. J. Biol. Macromol. 323(Pt 2) (2025) 147073].

Journal: International journal of biological macromolecules

Published: July 08, 2026

Ameliorating Acute Kidney Injury Induced by Ischemia-Reperfusion by Targeting Purine Metabolism.

Ameliorating Acute Kidney Injury Induced by Ischemia-Reperfusion by Targeting Purine Metabolism.

Journal: International journal of molecular sciences

Published: November 14, 2025

The clinical value of metabolic indicators in immunoglobulin A nephropathy.

The clinical value of metabolic indicators in immunoglobulin A nephropathy.

Journal: Frontiers in medicine

Published: November 05, 2025

Irisin improves acute kidney injury induced by ischemia-reperfusion through targeting energy metabolism reprogramming.

Irisin improves acute kidney injury induced by ischemia-reperfusion through targeting energy metabolism reprogramming.

Journal: International journal of biological macromolecules

Published: May 06, 2025

Copper-instigated modulatory cell mortality mechanisms and progress in kidney diseases.

Copper-instigated modulatory cell mortality mechanisms and progress in kidney diseases.

Journal: Renal failure

Published: January 13, 2025

Irisin Is a Potential Novel Biomarker and Therapeutic Target Against Kidney Diseases.

Irisin Is a Potential Novel Biomarker and Therapeutic Target Against Kidney Diseases.

Journal: Cell biochemistry and function

Published: November 04, 2024

β-Hydroxybutyrate Protects Against Cisplatin-Induced Renal Damage via Regulating Ferroptosis.

β-Hydroxybutyrate Protects Against Cisplatin-Induced Renal Damage via Regulating Ferroptosis.

Journal: Renal failure

Published: May 17, 2024

Regulation of macrophage polarization by targeted metabolic reprogramming for the treatment of lupus nephritis.

Regulation of macrophage polarization by targeted metabolic reprogramming for the treatment of lupus nephritis.

Journal: Molecular medicine (Cambridge, Mass.)

Published: April 16, 2024

Gut microbiota mediates the protective effects of β-hydroxybutyrate against cisplatin-induced acute kidney injury.

Gut microbiota mediates the protective effects of β-hydroxybutyrate against cisplatin-induced acute kidney injury.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 30, 2024

Energy metabolic reprogramming regulates programmed cell death of renal tubular epithelial cells and might serve as a new therapeutic target for acute kidney injury.

Energy metabolic reprogramming regulates programmed cell death of renal tubular epithelial cells and might serve as a new therapeutic target for acute kidney injury.

Journal: Frontiers in cell and developmental biology

Published: August 11, 2023

Unveiling the potential of mitochondrial dynamics as a therapeutic strategy for acute kidney injury.

Unveiling the potential of mitochondrial dynamics as a therapeutic strategy for acute kidney injury.

Journal: Frontiers in cell and developmental biology

Published: June 22, 2023

Iron metabolism-related indicators as predictors of the incidence of acute kidney injury after cardiac surgery: a meta-analysis.

Iron metabolism-related indicators as predictors of the incidence of acute kidney injury after cardiac surgery: a meta-analysis.

Journal: Renal failure

Published: April 19, 2023

Showing 1-12 of 12

Last Updated: 09/26/2026